patient with histologically prove malignant glioma will be eligible for this protocol malignant glioma include glioblastoma multiforme gbm anaplastic astrocytoma aa anaplastic oligodendroglioma ao anaplastic mix oligoastrocytoma amo or malignant glioma no not otherwise specify additionally patient with primitive neuroectodermal tumor pnets of the central nervous system progressive low-grade glioma and radiographically diagnose brain stem glioma refractory to standard treatment will be eligible 